Radiopharmaceutical Production & Packaging Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast Period

 

The radiopharmaceutical production and packaging market was estimated to be worth USD 7.9 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 10.9% from 2024 to 2034, reaching USD 24.1 billion in 2034. The manufacturing and packaging of radiopharmaceuticals allows for accurate diagnostic imaging and tailored treatments, which greatly improve patient care and treatment results. The market is increasing and sustainable since it is in line with the healthcare industry.

Radioactive substances used in medical diagnostics and therapies are created and prepared as part of the production and packaging of radiopharmaceuticals. The preparation and packing of the entire radiopharmaceutical as well as the synthesis of the radionuclide that serves as the foundation for the pharmaceutical are the two processes involved in the radiopharmaceutical. These substances, which have the ability to target particular organs or tissues, are essential for techniques like single photon emission computed tomography and positron emission tomography, as well as for targeted radiation in the treatment of cancer.

 

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/radiopharmaceutical-production-packaging-market

 

GROWTH DRIVERS

The demand for radiopharmaceuticals has been significantly boosted by the rise in cancer and cardiovascular illnesses worldwide. The market for production and packaging is driven by the importance of targeted radionuclide therapy and diagnostic imaging. With an estimated 9.6 million deaths, or 1 in 6 lives, cancer is the second greatest cause of mortality worldwide, according to the World Health Organization. Globally, the number of new cases of cancer is expected to increase by 77% between 2022 and 2050. According to the American Cancer Society (ACS), the number of new instances of cancer is rising even as cancer deaths are decreasing.

The demographics of cancer patients are changing as well; middle-aged individuals are receiving more diagnoses than elderly folks. Worldwide, there has also been an increase in early-onset malignancies, which are defined as tumors diagnosed in those under 50. The development of more potent radiopharmaceuticals is a result of technological advancements in nuclear medicine. Advances such as Single Photon Emission Computed Tomography and Positron Emission Tomography improve treatment results and diagnostic precision.

MARKET SEGMENTATION:

·         By Production Method- cyclotron production, nuclear reactor production, generator production, and others.

·         By Product Type- Synthesis Equipment [(Automated synthesis modules- Reaction members, Synthesis software, reagent dispensers, purification modules) hot cells- lead lined glass windows, manipulator arms, remote handling tools)], Quality control instruments- gamma counters, high-performance liquid chromatography (HLPC) systems and others, Dispensing system- automated dispensing systems, packaging type [ shielding materials( lead shielding, lead glasses and goggles, tungsten shielding, concrete and barite concrete, polyethylene and plastic shields, boron based shields other) , container type (lead lined vials, shielded transport containers, PET drug containers, disposable shields, shielded dispensing units)] and others

·         By Application- diagnostic radiopharmaceuticals (PET radiopharmaceuticals and SPECT radiopharmaceuticals) and therapeutic radiopharmaceuticals (alpha emitters, beta emitters, gamma emitters, positron emitters, brachytherapy sources)

·         By End-User- Hospitals and clinics, diagnostics centers, contract manufacturing organizations and research institutions

·         By Region- North America, Europe, Asia Pacific, The Middle East and Africa, South America

Global Key Players:

·         Von Gahlen

·         COMECER S.p.A.

·         ANSTO

·         ACIC Pharmaceuticals Inc.

·         Nordion (Canada) Inc.

·         Eckert & Ziegler AG

·         Lemer Pax

·         Mirion Technologies, Inc.

·         TTG Imaging Solutions, LLC

·         Other Players

For More Information about this Report @ https://www.xresearch.biz/shop/radiopharmaceutical-production-packaging-market

 

About Us: -  

xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

                                   

Contact:                                           
Company Name:  xResearch
Contact Person:  James Lin
Email:  sales@xresearch.biz
Phone: +1 718-619-8140